<?xml version='1.0' encoding='utf-8'?>
<document id="27145339"><sentence text="Inhibition of UDP-Glucuronosyltransferase (UGT) Isoforms by Arctiin and Arctigenin."><entity charOffset="72-82" id="DDI-PubMed.27145339.s1.e0" text="Arctigenin" /></sentence><sentence text="Arctiin is the major pharmacological ingredient of Fructus Arctii, and arctigenin is the metabolite of arctiin formed via the catalysis of human intestinal bacteria"><entity charOffset="0-7" id="DDI-PubMed.27145339.s2.e0" text="Arctiin" /><entity charOffset="71-81" id="DDI-PubMed.27145339.s2.e1" text="arctigenin" /><entity charOffset="103-110" id="DDI-PubMed.27145339.s2.e2" text="arctiin" /><pair ddi="false" e1="DDI-PubMed.27145339.s2.e0" e2="DDI-PubMed.27145339.s2.e0" /><pair ddi="false" e1="DDI-PubMed.27145339.s2.e0" e2="DDI-PubMed.27145339.s2.e1" /><pair ddi="false" e1="DDI-PubMed.27145339.s2.e0" e2="DDI-PubMed.27145339.s2.e2" /><pair ddi="false" e1="DDI-PubMed.27145339.s2.e1" e2="DDI-PubMed.27145339.s2.e1" /><pair ddi="false" e1="DDI-PubMed.27145339.s2.e1" e2="DDI-PubMed.27145339.s2.e2" /></sentence><sentence text=" The present study aims to investigate the inhibition profile of arctiin and arctigenin on important phase II drug-metabolizing enzymes UDP-glucuronosyltransferases (UGTs), indicating the possible herb-drug interaction"><entity charOffset="65-72" id="DDI-PubMed.27145339.s3.e0" text="arctiin" /><entity charOffset="77-87" id="DDI-PubMed.27145339.s3.e1" text="arctigenin" /><pair ddi="false" e1="DDI-PubMed.27145339.s3.e0" e2="DDI-PubMed.27145339.s3.e0" /><pair ddi="false" e1="DDI-PubMed.27145339.s3.e0" e2="DDI-PubMed.27145339.s3.e1" /></sentence><sentence text=" In vitro screening experiment showed that 100 μM of arctiin and arctigenin inhibited the activity of UGT1A3, 1A9, 2B7, and 2B15"><entity charOffset="53-60" id="DDI-PubMed.27145339.s4.e0" text="arctiin" /><entity charOffset="65-75" id="DDI-PubMed.27145339.s4.e1" text="arctigenin" /><pair ddi="false" e1="DDI-PubMed.27145339.s4.e0" e2="DDI-PubMed.27145339.s4.e0" /><pair ddi="false" e1="DDI-PubMed.27145339.s4.e0" e2="DDI-PubMed.27145339.s4.e1" /></sentence><sentence text=" Homology modeling-based in silico docking of arctiin and arctigenin into the activity cavity of UGT2B15 showed that hydrogen bonds and hydrophobic interactions contributed to the strong binding free energy of arctiin (-8"><entity charOffset="46-53" id="DDI-PubMed.27145339.s5.e0" text="arctiin" /><entity charOffset="58-68" id="DDI-PubMed.27145339.s5.e1" text="arctigenin" /><entity charOffset="117-125" id="DDI-PubMed.27145339.s5.e2" text="hydrogen" /><entity charOffset="210-217" id="DDI-PubMed.27145339.s5.e3" text="arctiin" /><pair ddi="false" e1="DDI-PubMed.27145339.s5.e0" e2="DDI-PubMed.27145339.s5.e0" /><pair ddi="false" e1="DDI-PubMed.27145339.s5.e0" e2="DDI-PubMed.27145339.s5.e1" /><pair ddi="false" e1="DDI-PubMed.27145339.s5.e0" e2="DDI-PubMed.27145339.s5.e2" /><pair ddi="false" e1="DDI-PubMed.27145339.s5.e0" e2="DDI-PubMed.27145339.s5.e3" /><pair ddi="false" e1="DDI-PubMed.27145339.s5.e1" e2="DDI-PubMed.27145339.s5.e1" /><pair ddi="false" e1="DDI-PubMed.27145339.s5.e1" e2="DDI-PubMed.27145339.s5.e2" /><pair ddi="false" e1="DDI-PubMed.27145339.s5.e1" e2="DDI-PubMed.27145339.s5.e3" /><pair ddi="false" e1="DDI-PubMed.27145339.s5.e2" e2="DDI-PubMed.27145339.s5.e2" /><pair ddi="false" e1="DDI-PubMed.27145339.s5.e2" e2="DDI-PubMed.27145339.s5.e3" /></sentence><sentence text="14 kcal/mol) and arctigenin (-8"><entity charOffset="17-27" id="DDI-PubMed.27145339.s6.e0" text="arctigenin" /></sentence><sentence text="43 kcal/mol) with UGT2B15" /><sentence text=" Inhibition kinetics study showed that arctiin and arctigenin exerted competitive and noncompetitive inhibition toward UGT2B15, respectively"><entity charOffset="39-46" id="DDI-PubMed.27145339.s8.e0" text="arctiin" /><entity charOffset="51-61" id="DDI-PubMed.27145339.s8.e1" text="arctigenin" /><pair ddi="false" e1="DDI-PubMed.27145339.s8.e0" e2="DDI-PubMed.27145339.s8.e0" /><pair ddi="false" e1="DDI-PubMed.27145339.s8.e0" e2="DDI-PubMed.27145339.s8.e1" /></sentence><sentence text=" The inhibition kinetic parameters (Ki ) were calculated to be 16" /><sentence text="0 and 76" /><sentence text="7 μM for the inhibition of UGT2B15 by arctiin and arctigenin, respectively"><entity charOffset="50-60" id="DDI-PubMed.27145339.s11.e0" text="arctigenin" /></sentence><sentence text=" Based on the plasma concentration of arctiin and arctigenin after administration of 100 mg/kg of arctiin, the [I]/Ki values were calculated to be 0"><entity charOffset="38-45" id="DDI-PubMed.27145339.s12.e0" text="arctiin" /><entity charOffset="50-60" id="DDI-PubMed.27145339.s12.e1" text="arctigenin" /><entity charOffset="98-105" id="DDI-PubMed.27145339.s12.e2" text="arctiin" /><pair ddi="false" e1="DDI-PubMed.27145339.s12.e0" e2="DDI-PubMed.27145339.s12.e0" /><pair ddi="false" e1="DDI-PubMed.27145339.s12.e0" e2="DDI-PubMed.27145339.s12.e1" /><pair ddi="false" e1="DDI-PubMed.27145339.s12.e0" e2="DDI-PubMed.27145339.s12.e2" /><pair ddi="false" e1="DDI-PubMed.27145339.s12.e1" e2="DDI-PubMed.27145339.s12.e1" /><pair ddi="false" e1="DDI-PubMed.27145339.s12.e1" e2="DDI-PubMed.27145339.s12.e2" /></sentence><sentence text="3 and 0" /><sentence text="007 for arctiin and arctigenin, respectively"><entity charOffset="8-15" id="DDI-PubMed.27145339.s14.e0" text="arctiin" /><entity charOffset="20-30" id="DDI-PubMed.27145339.s14.e1" text="arctigenin" /><pair ddi="false" e1="DDI-PubMed.27145339.s14.e0" e2="DDI-PubMed.27145339.s14.e0" /><pair ddi="false" e1="DDI-PubMed.27145339.s14.e0" e2="DDI-PubMed.27145339.s14.e1" /></sentence><sentence text=" Based on the inhibition evaluation standard ([I]/Ki  &lt; 0" /><sentence text="1, low possibility; 0" /><sentence text="1 &lt; [I]/Ki  &lt; 1, medium possibility; [I]/Ki  &gt; 1, high possibility), arctiin might induce drug-drug interaction with medium possibility"><entity charOffset="69-76" id="DDI-PubMed.27145339.s17.e0" text="arctiin" /></sentence><sentence text=" Based on these results, clinical monitoring the utilization of Fructus Arctii is very important and necessary" /><sentence text=" Copyright © 2016 John Wiley &amp; Sons, Ltd" /><sentence text=" " /></document>